Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, H1, 2012

• Publication date: May 2012
• Report size: 155 pages

Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, H1, 2012 Summary GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, H1, 2012" provides data on the Ankylosing Spondylitis (Bekhterev’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ankylosing...

Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, H1, 2012



Summary



GlobalData's clinical trial report, “Ankylosing Spondylitis (Bekhterev’s Disease) Global Clinical Trials Review, H1, 2012" provides data on the Ankylosing Spondylitis (Bekhterev’s Disease) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ankylosing Spondylitis (Bekhterev’s Disease). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ankylosing Spondylitis (Bekhterev’s Disease). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.



Scope


- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)



Reasons to buy


- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Global Drug Discovery And Development Industry

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Ankylosing Spondylitis (Bekhterev’s Disease) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of Ankylosing Spondylitis (Bekhterev’s Disease) 25
Subjects Recruited Over a Period of Time 28
Prominent Sponsors 29
Top Companies Participating in Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials 31
Prominent Drug Comparison 33
Clinical Trial Profiles 34
Clinical Trial Overview of Top Companies 34
Pfizer Inc. 34
Clinical Trial Overview of Pfizer Inc. 34
Abbott Laboratories 36
Clinical Trial Overview of Abbott Laboratories 36
Merck & Co., Inc. 38
Clinical Trial Overview of Merck & Co., Inc. 38
AstraZeneca PLC 39
Clinical Trial Overview of AstraZeneca PLC 39
Johnson & Johnson 40
Clinical Trial Overview of Johnson & Johnson 40
Teva Pharmaceutical Industries Limited 41
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 41
Boehringer Ingelheim GmbH 42
Clinical Trial Overview of Boehringer Ingelheim GmbH 42
Sanofi 43
Clinical Trial Overview of Sanofi 43
POZEN Inc. 44
Clinical Trial Overview of POZEN Inc. 44
Janssen Biotech, Inc. 45
Clinical Trial Overview of Janssen Biotech, Inc. 45
Schering-Plough Limited 46
Clinical Trial Overview of Schering-Plough Limited 46
Janssen Korea Ltd. 47
Clinical Trial Overview of Janssen Korea Ltd. 47
Array BioPharma Inc. 48
Clinical Trial Overview of Array BioPharma Inc. 48
Schering-Plough Corporation (Inactive) 49
Clinical Trial Overview of Schering-Plough Corporation (Inactive) 49
Celgene Corporation 50
Clinical Trial Overview of Celgene Corporation 50
Mitsubishi Tanabe Pharma Corporation 51
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 51
Novartis AG 52
Clinical Trial Overview of Novartis AG 52
Celltrion, Inc. 53
Clinical Trial Overview of Celltrion, Inc. 53
Otsuka Pharmaceutical Co., Ltd. 54
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 54
AmpliPhi Biosciences Corporation 55
Clinical Trial Overview of AmpliPhi Biosciences Corporation 55
Clinical Trial Overview of Top Universities / Institutes / Hospitals 56
Charite- Universitatsmedizin Berlin 56
Clinical Trial Overview of Charite- Universitatsmedizin Berlin 56
Sun Yat-sen University 57
Clinical Trial Overview of Sun Yat-sen University 57
University of Sao Paulo 58
Clinical Trial Overview of University of Sao Paulo 58
Federal University of Sao Paulo 59
Clinical Trial Overview of Federal University of Sao Paulo 59
Goteborg University 60
Clinical Trial Overview of Goteborg University 60
Imperial College London 61
Clinical Trial Overview of Imperial College London 61
University of Zurich 62
Clinical Trial Overview of University of Zurich 62
Academic Medical Centre 63
Clinical Trial Overview of Academic Medical Centre 63
Diakonhjemmet Hospital 64
Clinical Trial Overview of Diakonhjemmet Hospital 64
Swansea University 65
Clinical Trial Overview of Swansea University 65
Shandong University 66
Clinical Trial Overview of Shandong University 66
Instituto De Medicina Molecular 67
Clinical Trial Overview of Instituto De Medicina Molecular 67
Silkeborg Regional Hospital 68
Clinical Trial Overview of Silkeborg Regional Hospital 68
Asan Medical Center 69
Clinical Trial Overview of Asan Medical Center 69
Association de Recherche Clinique en Rhumatologie 70
Clinical Trial Overview of Association de Recherche Clinique en Rhumatologie 70
Far Eastern Memorial Hospital 71
Clinical Trial Overview of Far Eastern Memorial Hospital 71
Hvidovre University Hospital 72
Clinical Trial Overview of Hvidovre University Hospital 72
University Hospital, Tours 73
Clinical Trial Overview of University Hospital, Tours 73
Tel-Aviv Sourasky Medical Center 74
Clinical Trial Overview of Tel-Aviv Sourasky Medical Center 74
Chinese University of Hong Kong 75
Clinical Trial Overview of Chinese University of Hong Kong 75
Five Key Clinical Profiles 76
Appendix 152
Abbreviations 152
Definitions 152
Research Methodology 153
Secondary Research 153
About GlobalData 154
Contact Us 154
Disclaimer 154
Source 155

List of Tables

Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Zone, 2012* 9
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 12
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 13
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, North America, Top Countries, 2012* 14
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 15
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Central and South America, Top Countries, 2012* 16
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, BRIC Countries, 2012* 17
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, G7 Countries, 2012* 18
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, E7 Countries, 2012* 20
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Phase, 2012* 22
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 23
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Suspended Clinical Trials, 2012* 25
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 26
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Terminated Clinical Trials, 2012* 27
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 34
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012* 36
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012* 38
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 39
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2012* 40
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2012* 41
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Boehringer Ingelheim GmbH, 2012* 42
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012* 43
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by POZEN Inc., 2012* 44
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Biotech, Inc., 2012* 45
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Limited, 2012* 46
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Janssen Korea Ltd., 2012* 47
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Array BioPharma Inc., 2012* 48
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Schering-Plough Corporation (Inactive), 2012* 49
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celgene Corporation, 2012* 50
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2012* 51
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2012* 52
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Celltrion, Inc., 2012* 53
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Otsuka Pharmaceutical Co., Ltd., 2012* 54
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by AmpliPhi Biosciences Corporation, 2012* 55
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite- Universitatsmedizin Berlin, 2012* 56
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Yat-sen University, 2012* 57
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Sao Paulo, 2012* 58
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Federal University of Sao Paulo, 2012* 59
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Goteborg University, 2012* 60
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Imperial College London, 2012* 61
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Zurich, 2012* 62
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2012* 63
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Diakonhjemmet Hospital, 2012* 64
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Swansea University, 2012* 65
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong University, 2012* 66
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Instituto De Medicina Molecular, 2012* 67
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Silkeborg Regional Hospital, 2012* 68
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2012* 69
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Association de Recherche Clinique en Rhumatologie, 2012* 70
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Far Eastern Memorial Hospital, 2012* 71
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Hvidovre University Hospital, 2012* 72
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Tours, 2012* 73
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Tel-Aviv Sourasky Medical Center, 2012* 74
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2012* 75

List of Figures

Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 9
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 10
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 11
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 12
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 13
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 14
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 15
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012* 16
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, BRIC Countries (%), 2012* 17
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, G7 Countries (%), 2012* 18
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 19
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, E7 Countries (%), 2012* 20
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 21
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 22
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 23
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 24
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2006-2011 28
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31
Ankylosing Spondylitis (Bekhterev’s Disease) Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33
GlobalData Methodology 153